Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
GI	B-Upper_gastrointestinal_haemorrhage
bleed	B-Upper_gastrointestinal_haemorrhage
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Upper	O
endoscopy	O
___	O
Gastroduodenal	O
artery	O
embolization	O
___	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
a	O
___	O
male	O
with	O
pmhx	O
of	O
afib,	O
CHF,	O
CAD	O
who	O
presented	O
with	O
anemia,	O
abdominal	O
pain	O
and	O
found	O
to	O
have	O
large,	O
bleeding	B-Upper_gastrointestinal_haemorrhage
duodenal	B-Upper_gastrointestinal_haemorrhage
mass,	O
omental	O
and	O
liver	O
metastatic	O
involvement.	O
The	O
patient	O
was	O
initially	O
diagnosed	O
with	O
cancer	O
involving	O
his	O
liver	O
in	O
___,	O
and	O
was	O
then	O
found	O
to	O
have	O
omental	O
involvement.	O
Both	O
sites	O
were	O
biopsied	O
but	O
the	O
pathology	O
was	O
undifferentiated	O
cancer.	O
He	O
was	O
found	O
to	O
have	O
worsening	O
anemia,	O
with	O
Hgb	O
9	O
and	O
Hct	O
29	O
at	O
OSH	O
on	O
___.	O
EGD	O
revealed	O
3cm	O
duodenal	O
mass,	O
which	O
was	O
injected	O
with	O
epinephrine	O
and	O
biopsied.	O
The	O
GI	O
team	O
consulted	O
___	O
for	O
plan	O
for	O
gastroduodenal	O
artery	O
embolization	O
planned	O
for	O
___,	O
and	O
Dr	O
___	O
of	O
surg	O
onc	O
was	O
also	O
made	O
aware	O
of	O
the	O
patient.	O
He	O
remained	O
hemodynamically	O
stable	O
in	O
the	O
EGD	O
suite.	O
He	O
was	O
recommended	O
to	O
have	O
BID	O
IV	O
PPI,	O
PIV,	O
T&C.	O
In	O
speaking	O
to	O
the	O
patient,	O
he	O
reports	O
that	O
since	O
___,	O
he	O
has	O
been	O
feeling	O
unwell.	O
He	O
had	O
diarrhea,	O
pain.	O
In	O
___,	O
he	O
had	O
EGD	O
which	O
was	O
negative.	O
US	O
and	O
CT	O
scan	O
of	O
abdomen	O
showed	O
liver	O
mets,	O
and	O
he	O
was	O
referred	O
to	O
___.	O
Review	O
of	O
Systems:	O
(+)	O
Per	O
HPI	O
bright	O
light	O
flashes	B-Visual_impairment
when	B-Visual_impairment
looking	B-Visual_impairment
at	B-Visual_impairment
bright	B-Visual_impairment
lights	B-Visual_impairment
(ie	O
sun	O
on	O
snow)	O
for	O
2	O
days,	O
fatigue,	O
abdominal	O
pain,	O
shoulder	O
pain,	O
night	O
sweats,	O
30lb	O
weight	B-Weight_loss
loss	B-Weight_loss
since	O
___	O
and	O
6	O
lbs	O
in	O
past	O
few	O
weeks,	O
fever	O
to	O
99	O
degrees	O
a	O
few	O
nights	O
ago,	O
anorexia.	O
Abd	O
pain	O
is	O
controlled	O
with	O
5mg/daily	O
of	O
oxycodone.	O
Black	B-Upper_gastrointestinal_haemorrhage
stools,	B-Upper_gastrointestinal_haemorrhage
nausea	O
initially	O
but	O
resolved	O
in	O
___.	O
No	O
hematochezia.	B-Lower_gastrointestinal_haemorrhage
Urinary	O
dripping,	O
and	O
nocturia.	O
Rhinorrhea	O
Past	O
Medical	O
History:	O
PAST	O
ONCOLOGIC	O
HISTORY:	O
-	O
___:	O
liver	O
mass	O
on	O
imaging	O
done	O
for	O
abdominal	O
pain	O
-	O
___:	O
liver	O
biopsy	O
shows	O
undifferentiated	O
neoplasm-	O
differential	O
includes	O
lymphoma	O
vs	O
neuroendocrine	O
tumor.	O
-	O
___:	O
OR	O
for	O
omental	O
biopsy	O
and	O
port	O
placement,	O
omental	O
biopsy	O
still	O
unrevealing.	O
-	O
___:	O
patient	O
found	O
to	O
have	O
worsening	O
anemia	O
(H/H	O
___	O
-	O
___:	O
EGD	O
done	O
for	O
persistent	O
anemia	O
and	O
guaiac	O
positive	O
stool	O
revealing	O
bleeding	B-Upper_gastrointestinal_haemorrhage
duodenal	B-Upper_gastrointestinal_haemorrhage
mass;	O
biopsy	O
done.	O
PAST	O
MEDICAL	O
HISTORY:	O
-	O
CAD	O
s/p	O
stent	O
___	O
-	O
CHF	O
with	O
ICD	O
in	O
place	O
(EF	O
was	O
___	O
per	O
pt	O
report)	O
-	O
AFib	O
-	O
DM	O
-	O
BPH	O
-	O
hyperlipidemia	O
-	O
HTN	O
-	O
colon	O
polyps	O
and	O
diverticulosis	O
-	O
rotator	O
cuff	O
injury	O
s/p	O
repair	O
(Dr.	O
___	O
-	O
overweight	O
-	O
hx	O
of	O
cellulitis	O
-	O
sebaceous	O
cyst	O
-	O
detached	B-Visual_impairment
retina	B-Visual_impairment
(right)	O
-	O
gastroparesis	O
-	O
infrarenal	O
abdominal	O
aortic	O
anuerysm	O
Social	O
History:	O
___	O
Family	O
History:	O
non	O
contributory	O
Physical	O
Exam:	O
ADMISSION	O
EXAM	O
Vitals:	O
HR	O
67	O
RR	O
20	O
BP	O
118/57	O
100%	O
on	O
RA	O
GENERAL:	O
thin	O
but	O
generally	O
well	O
appearing.	O
head	O
tremor.	O
CARDIAC:	O
no	O
m/r/g.	O
RRR.	O
ICD	O
incision	O
well	O
healed.	O
LUNG:	O
CTAB.	O
No	O
wheezes	O
ABDOMEN:	O
NTTP.	O
Non	O
distended.	O
No	O
guarding.	O
Very	O
small	O
incisions	O
are	O
well	O
healed.	O
EXTREMITIES:	O
no	O
pitting	O
edema	O
PULSES:	O
2+	O
in	O
extremities	O
DISCHARGE	O
EXAM:	O
VSS	O
General:	O
well	O
appearing,	O
NAD	O
HEENT:	O
MMM,	O
NCAT	O
Lungs:	O
CTAB	O
CV:	O
RRR,	O
no	O
m/r/g	O
Abd:	O
mildly	O
TTP	O
diffusely,	O
soft,	O
non-distended,	O
no	O
rebound	O
or	O
guarding	O
Ext:	O
no	O
pitting	O
edema	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
___	O
04:45PM	O
BLOOD	O
WBC-9.7	O
RBC-3.46*	O
Hgb-8.2*	O
Hct-26.9*	O
MCV-78*	O
MCH-23.7*	O
MCHC-30.5*	O
RDW-13.6	O
Plt	O
___	O
___	O
04:45PM	O
BLOOD	O
Neuts-83.3*	O
Lymphs-8.4*	O
Monos-6.0	O
Eos-1.7	O
Baso-0.6	O
___	O
04:45PM	O
BLOOD	O
___	O
PTT-41.2*	O
___	O
___	O
04:45PM	O
BLOOD	O
Glucose-191*	O
UreaN-30*	O
Creat-1.8*	O
Na-138	O
K-4.0	O
Cl-104	O
HCO3-23	O
AnGap-15	O
___	O
04:45PM	O
BLOOD	O
ALT-16	O
AST-26	O
AlkPhos-91	O
TotBili-0.2	O
___	O
04:45PM	O
BLOOD	O
Calcium-8.7	O
Phos-3.4	O
Mg-2.0	O
Iron-14*	O
___	O
04:45PM	O
BLOOD	O
calTIBC-250*	O
Ferritn-337	O
TRF-192*	O
DISCHARGE	O
LABS:	O
___	O
06:05AM	O
BLOOD	O
WBC-15.9*	O
RBC-4.21*	O
Hgb-10.9*	O
Hct-35.0*	O
MCV-83	O
MCH-25.9*	O
MCHC-31.2	O
RDW-16.0*	O
Plt	O
___	O
___	O
06:05AM	O
BLOOD	O
___	O
PTT-41.0*	O
___	O
___	O
06:05AM	O
BLOOD	O
Glucose-147*	O
UreaN-20	O
Creat-1.4*	O
Na-139	O
K-4.1	O
Cl-103	O
HCO3-24	O
AnGap-16	O
___	O
06:05AM	O
BLOOD	O
Calcium-8.4	O
Phos-3.4	O
Mg-1.8	O
MICRO:	O
none	O
IMAGING/STUDIES:	O
EGD	O
___	O
Impression:	O
Erythema	O
and	O
granularity	O
in	O
the	O
antrum	O
Mass	O
in	O
the	O
duodenal	B-Upper_gastrointestinal_haemorrhage
bulb	O
with	O
active	O
oozing.	O
Given	O
the	O
uncertainty	O
regarding	O
tissue	O
type	O
on	O
prior	O
biopsies,	O
a	O
small	O
additional	O
biopsy	O
was	O
taken	O
of	O
the	O
mass	O
Epinephrine	O
was	O
injected	O
locally	O
to	O
help	O
temporize	O
bleeding.	B-Upper_gastrointestinal_haemorrhage
However,	O
endoscopic	O
management	O
of	O
bleeding	O
malignancy	O
is	O
generally	O
not	O
definitive	O
because	O
of	O
the	O
vascular/oozing	O
surface	O
of	O
the	O
mass.	O
Cautery	O
and	O
clipping	O
are	O
unlikely	O
to	O
be	O
effective.	O
Otherwise	O
normal	O
EGD	O
to	O
second	O
part	O
of	O
the	O
duodenum	O
Upper	O
intestinal	O
biopsy	O
pathology	O
___:	O
report	O
pending	O
___	O
embolization	O
procedure	O
___:	O
1.	O
Small	O
branches	O
arising	O
from	O
the	O
gastroduodenal	O
artery	O
supplying	O
the	O
duodenal	O
tumor.	O
2.	O
Complete	O
stasis	O
in	O
the	O
gastroduodenal	O
artery	O
following	O
embolization.	O
3.	O
Questionable	O
blood	O
supply	O
from	O
an	O
inferior	O
pancreaticoduodenal	O
branch	O
arising	O
off	O
the	O
proximal	O
SMA.	O
IMPRESSION:	O
Embolization	O
of	O
the	O
GDA	O
supplying	O
the	O
duodenal	O
mass.	O
If	O
bleeding	O
continues,	O
further	O
selective	O
embolization	O
can	O
be	O
carried	O
out	O
in	O
the	O
proximal	O
branches	O
of	O
the	O
SMA.	O
KUB	O
___:	O
IMPRESSION:	O
Unremarkable	O
bowel	O
gas	O
pattern.	O
No	O
evidence	O
of	O
perforation	O
or	O
intraperitoneal	O
free	O
air.	O
Brief	O
Hospital	O
Course:	O
___	O
y/o	O
male	O
with	O
recent	O
diagnosis	O
of	O
metastatic	O
poorly	O
differentiated	O
carcinoma	O
with	O
unknown	O
primary	O
presented	O
with	O
several	O
days	O
of	O
melena	B-Upper_gastrointestinal_haemorrhage
___	O
bleeding	B-Upper_gastrointestinal_haemorrhage
duodenal	B-Upper_gastrointestinal_haemorrhage
mass,	O
s/p	O
unsuccessful	O
endoscopic	O
control,	O
with	O
subsequent	O
successful	O
___	O
embolization	O
of	O
gastroduodenal	O
artery	O
#	O
GIB:	B-Upper_gastrointestinal_haemorrhage
Pt	O
presented	O
with	O
melena	B-Upper_gastrointestinal_haemorrhage
and	O
low	O
hct.	O
Had	O
EGD	O
___	O
which	O
showed	O
a	O
bleeding	B-Upper_gastrointestinal_haemorrhage
duodenal	B-Upper_gastrointestinal_haemorrhage
mass	O
___	O
portion),	O
bx	O
was	O
taken	O
for	O
tissue	O
analysis.	O
Additionally,	O
epi	O
was	O
injected	O
in	O
attempts	O
to	O
stem	O
the	O
bleeding	O
but	O
was	O
unsuccessful.	O
He	O
underwent	O
___	O
embolizatin	O
of	O
GDA	O
___	O
without	O
further	O
episodes	O
of	O
melena.	B-Upper_gastrointestinal_haemorrhage
Pt	O
had	O
some	O
expected	O
post-procedure	O
abdominal	O
pain	O
without	O
signs	O
of	O
ischemia	O
or	O
perforation	O
and	O
this	O
was	O
improving	O
at	O
discharge.	O
Hct	O
uptrending	O
at	O
time	O
of	O
discharge	O
as	O
well.	O
#	O
Unknown	O
Malignancy:	O
Pt	O
s/p	O
biopsies	O
of	O
liver	O
mass	O
and	O
peritoneal	O
implant	O
showing	O
undifferentiated	O
cancer	O
(stains	O
negative	O
for	O
all	O
epithelial,	O
lymphoid,	O
endothelial	O
and	O
melanoma	O
or	O
neuroendocrine	O
markers).	O
Pathology	O
from	O
duodenal	O
mass	O
pending.	O
Per	O
onc	O
they	O
are	O
planning	O
to	O
start	O
chemo,	O
however	O
are	O
holding	O
off	O
for	O
now	O
given	O
acute	O
illness.	O
Per	O
surg-onc,	O
they	O
do	O
not	O
want	O
to	O
do	O
any	O
surigcal	O
interventions	O
at	O
this	O
time.	O
The	O
patient	O
should	O
follow	O
up	O
with	O
medical	O
and	O
surgical	O
oncology	O
as	O
an	O
outpatient.	O
#	O
Coagulopathy:	O
pt	O
with	O
high	O
INR	O
on	O
admission	O
of	O
2.4,	O
decreased	O
with	O
FFP	O
and	O
vitamin	O
K.	O
Likely	O
due	O
to	O
liver	O
dysfunction	O
from	O
metastatic	O
cancer	O
vs.	O
poor	B-Malnutrition
nutrition.	B-Malnutrition
Should	O
be	O
monitored	O
as	O
an	O
outpatient.	O
CHRONIC	O
ISSUES:	O
#	O
Renal	O
failure:	O
pt	O
with	O
creatinine	O
at	O
baseline	O
(around	O
1.7)	O
during	O
hospitalization.	O
#	O
Atrial	O
Fibrillation:	O
Remained	O
in	O
sinus	O
rhythm	O
and	O
normal	O
rate	O
during	O
admission.	O
Held	O
his	O
apixaban	O
during	O
admission	O
due	O
to	O
GIB.	B-Upper_gastrointestinal_haemorrhage
Was	O
not	O
restarted	O
at	O
discharge.	O
The	O
patient	O
should	O
follow	O
up	O
with	O
his	O
PCP	O
for	O
further	O
management.	O
#	O
CAD	O
s/p	O
stent	O
___:	O
Initially	O
anticoagulation	O
was	O
held	O
due	O
to	O
GIB;	B-Upper_gastrointestinal_haemorrhage
at	O
discharge	O
his	O
aspirin	O
was	O
restarted,	O
along	O
with	O
his	O
carvedilol.	O
#	O
CHF	O
with	O
ICD	O
in	O
place	O
(EF	O
was	O
___	O
per	O
pt	O
report):	O
Held	O
antihypertensives	O
and	O
diuretics	O
during	O
admission	O
due	O
to	O
GIB.	B-Upper_gastrointestinal_haemorrhage
Carvedilol	O
and	O
bumex	O
were	O
restarted	O
at	O
discharge.	O
He	O
should	O
follow	O
up	O
with	O
his	O
PCP	O
for	O
for	O
further	O
management.	O
#	O
DM:	O
Held	O
home	O
oral	O
diabetes	O
medications	O
while	O
admitted,	O
was	O
managed	O
with	O
sliding	O
scale	O
insulin.	O
TRANSITIONAL	O
ISSUES:	O
-	O
Held	O
the	O
patient's	O
anticoagulation	O
at	O
discharge.	O
He	O
should	O
f/u	O
with	O
his	O
PCP	O
for	O
further	O
management	O
-	O
Patient's	O
blood	O
pressure	O
medications	O
were	O
held	O
during	O
this	O
admission	O
and	O
only	O
carvedilol	O
and	O
bumex	O
were	O
restarted	O
at	O
discharge.	O
Others	O
should	O
be	O
restarted	O
gradually	O
as	O
blood	O
pressures	O
tolerate.	O
-	O
Biospies	O
from	O
EGD	O
are	O
pending	O
at	O
discharge	O
-	O
Should	O
get	O
creatinine	O
re-checked	O
on	O
___	O
given	O
recent	O
contrast	O
load	O
and	O
patient's	O
baseline	O
CKD	O
-	O
Patient	O
should	O
f/u	O
with	O
Hem/Onc	O
for	O
potential	O
treatment	O
of	O
his	O
metastatic	O
malignancy	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Apixaban	O
5	O
mg	O
PO	O
BID	O
2.	O
Bumetanide	O
0.5	O
mg	O
PO	O
DAILY	O
3.	O
Carvedilol	O
25	O
mg	O
PO	O
HS	O
4.	O
Carvedilol	O
12.5	O
mg	O
PO	O
QAM	O
5.	O
fenofibrate	O
120	O
mg	O
oral	O
daily	O
6.	O
Lisinopril	O
40	O
mg	O
PO	O
DAILY	O
7.	O
MetFORMIN	O
(Glucophage)	O
500	O
mg	O
PO	O
BID	O
8.	O
OxycoDONE	O
(Immediate	O
Release)	O
2.5	O
mg	O
PO	O
BID:PRN	O
pain	O
9.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
10.	O
Repaglinide	O
1	O
mg	O
PO	O
TIDAC	O
11.	O
Rosuvastatin	O
Calcium	O
40	O
mg	O
PO	O
DAILY	O
12.	O
Spironolactone	O
12.5	O
mg	O
PO	O
DAILY	O
13.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
HS	O
14.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
15.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
RX	O
*docusate	O
sodium	O
100	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*60	O
Capsule	O
Refills:*0	O
3.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
constipation	O
RX	O
*sennosides	O
[senna]	O
8.6	O
mg	O
1	O
tab	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
4.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q12H	O
RX	O
*pantoprazole	O
40	O
mg	O
1	O
tablet,delayed	O
release	O
(___)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*60	O
Tablet	O
Refills:*0	O
5.	O
OxycoDONE	O
(Immediate	O
Release)	O
___	O
mg	O
PO	O
Q4H:PRN	O
pain	O
RX	O
*oxycodone	O
5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
4	O
to	O
6	O
hours	O
Disp	O
#*20	O
Tablet	O
Refills:*0	O
6.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
7.	O
Bumetanide	O
0.5	O
mg	O
PO	O
DAILY	O
8.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
HS	O
9.	O
Carvedilol	O
25	O
mg	O
PO	O
HS	O
10.	O
Carvedilol	O
12.5	O
mg	O
PO	O
QAM	O
11.	O
fenofibrate	O
120	O
mg	O
oral	O
daily	O
12.	O
Repaglinide	O
1	O
mg	O
PO	O
TIDAC	O
13.	O
Rosuvastatin	O
Calcium	O
40	O
mg	O
PO	O
DAILY	O
14.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
RX	O
*ferrous	O
sulfate	O
325	O
mg	O
(65	O
mg	O
iron)	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
primary	O
diagnosis:	O
duodenal	O
mass	O
upper	B-Upper_gastrointestinal_haemorrhage
gastrointestinal	B-Upper_gastrointestinal_haemorrhage
bleed	B-Upper_gastrointestinal_haemorrhage
secondary	O
diagnosis:	O
congestive	O
heart	O
failure	O
atrial	O
fibrillation	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
during	O
your	O
stay.	O
You	O
were	O
admitted	O
due	O
GI	B-Upper_gastrointestinal_haemorrhage
bleeding,	B-Upper_gastrointestinal_haemorrhage
due	O
to	O
a	O
mass	O
in	O
your	O
small	B-Upper_gastrointestinal_haemorrhage
intestine.	B-Upper_gastrointestinal_haemorrhage
You	O
underwent	O
an	O
artery	O
embolization	O
in	O
order	O
to	O
stop	O
the	O
blood	O
supply	O
to	O
the	O
bleeding	O
mass.	O
Afterwards,	O
your	O
bleeding	O
resolved	O
and	O
your	O
blood	O
counts	O
remained	O
stable.	O
Please	O
continue	O
to	O
keep	O
your	O
appointments	O
with	O
your	O
physicians.	O
We	O
wish	O
you	O
all	O
the	O
best.	O
Your	O
___	O
medical	O
team	O
Followup	O
Instructions:	O
___	O

